Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol in Previously Treated B-Cell CLL
NCT00003620Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 1999
- Primary completion
- Jun 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alvocidib in chronic lymphocytic leukemia (CLL), sponsored by National Cancer Institute. Started Jun 1999; status: completed.
02
Drugs
alvocidib
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00003620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003620.